Pediatric anesthesia & critical care

Incidence of High Severity Anesthesia Related Adverse Events With Increasing PREDIC 3 T Risk Category in Congenital Cardiac Catheterization: A Review of the Catheterization Project on Outcomes (C3PO) Database

Paediatr AnaesthPublished Retrospective cohort study

Authors' conclusion

The overall rate of ARAE, including high severity ARAE, was found to be increased in higher PREDIC3T risk category procedures.

Study context

Population
Pediatric patients with congenital heart disease undergoing cardiac catheterization, C3PO database, 18 institutions, 2019–2023
Participants
38, 021 cardiac catheterizations
Exposure
High severity anesthesia related adverse events (ARAE) rates across PREDIC3T case-type risk categories, lowest (zero) to highest (5)
Outcome
High severity anesthesia related adverse events (ARAE, level 3bc/4/5) by PREDIC3T risk category
Methodological detailsmulticentre, prospectively collected registry data
  • Multicentre
  • Prospectively collected registry data

Main finding

As reported in the abstract

High severity ARAE (level 3bc/4/5) by PREDIC3T risk category

PREDIC3T zero

0.2%

Overall high severity ARAE
0.4%

Observational data: associations, not effects.

Further findings

ARAE of any severity (level 1-5)

Overall ARAE of any severity
321 (0.8%; CI, 0.7%-0.9%)

Factors associated with high severity ARAE (multivariable logistic regression)

Weight under 10 kg, hemodynamic vulnerability score (HVS) ≥ 1 and PREDIC3T risk category 5 procedures associated with higher odds of high severity ARAE

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Incidence of High Severity Anesthesia Related Adverse Events With Increasing PREDIC 3 T Risk Category in Congenital Cardiac Catheterization: A Review of the C3PO Database. Paediatr Anaesth. Published 31 December 2025. doi:10.1002/pan.70110

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.